Tresviri Korea

Korea has spent more than three decades as a permanent resident of MSCI’s Emerging Market index, watching from the sidelines as the $7.8 trillion Developed Market pool stays out of reach. The June 2025 review produced the same result it always does: no upgrade. Three analysts who have been watching this story closely — a … Read more

Korea’s PCB substrate sector has quietly become one of the most interesting debates in the domestic market — up-cycle fundamentals are improving across the board, yet Korean names continue to lag their Taiwanese and Japanese peers by a widening margin. Three of our regular analysts sat down to work through what’s actually happening and, more … Read more

Micron just delivered what might be the most discussed earnings print in the memory semiconductor industry’s recent history — a fiscal Q3 2026 result that didn’t just beat consensus, it embarrassed it. Revenue and EPS came in 16% and 21% above already-elevated expectations, with year-over-year EPS growth of 1,214%. But the number that matters most, … Read more

SK Hynix’s confirmation on June 24th that it will begin Nasdaq ADR trading on July 10th has cracked open one of the most consequential debates in Korean equity markets this year. The deal — 17.79 million new shares issued to Citibank as depositary, targeting approximately ₩45 trillion in proceeds — is either the beginning of … Read more

The KOSPI’s dramatic sell-off in late June 2026 — a single-day collapse of nearly 10%, the fifth-largest decline in the index’s history — sent shockwaves through Korean markets and triggered circuit breakers that halted trading entirely. Foreigners dumped ₩6.2 trillion in a single session, institutions added another ₩5.6 trillion in net selling, and retail investors … Read more

Korea’s ETF market has exploded from ₩121 trillion in AUM at end-2023 to crossing the ₩500 trillion threshold in May 2026 — a pace that has forced every serious analyst to reckon with what this means for KOSPI price dynamics. At the center of the debate sits a specific and uncomfortable question: are single-stock leveraged … Read more

When the KOSPI dropped over 12% across two trading sessions in August 2024 — and circuit breakers triggered on both KOSPI and KOSDAQ simultaneously in June 2025 — something cracked open beyond the numbers. Korean retail investors, already nursing wounds from a market that had barely risen before it fell, launched a national petition against … Read more

The great valuation debate of 2025 has a new battleground: AI semiconductor companies versus traditional software firms. With Nvidia’s market cap eclipsing the entire GDP of India, SK Hynix surpassing Samsung in market value on the back of HBM dominance, and Big Tech’s collective AI bill running into the trillions, investors are asking a fundamental … Read more

The Korean stock market has long been a battleground where individual investors — known affectionately and sometimes tragically as “개미” (ants) — go to war against a vastly more powerful set of opponents: foreign institutions, domestic funds, and the algorithmic machinery of professional trading desks. Recent market volatility, with the KOSPI suffering jaw-dropping single-day drops … Read more

Korea’s KOSDAQ biotech sector is lighting up trading screens in mid-2026, with a wave of small-cap biotech IPOs and share price surges drawing retail and institutional attention alike. But beneath the excitement lies a more complicated story — one of liquidity rotations, questionable valuations, and the age-old question of whether Korean small-caps are genuinely undervalued … Read more